How Many IVF Cycles Are Needed for Success in China? Reproductive Doctors Explain the Number of Cycles and Influencing Factors

There is no fixed answer to how many IVF cycles are needed for success in China. It depends on age, ovarian function, embryo quality, and uterine environment. The cumulative live birth rate after 3 cycles is about 70%-80% for women under 35, but drops significantly for those over 40. This article interprets key factors and clinical strategies affecting the number of successful cycles from a reproductive medicine perspective.

How Many IVF Cycles Are Needed for Success in China? Reproductive Doctors Explain the Number of Cycles and Influencing Factors
Surrogacy process 2026-07-07

Scene opening (check-up report scenario)

A 37-year-old woman enters the clinic with an AMH of 1.0 ng/mL and a history of two failed transfers. She asks, "Doctor, how many cycles do I need to succeed?" Behind this question lies a comprehensive consideration of time, cost, and physical endurance. From a reproductive medicine perspective, the answer must be based on individual assessment, not a one-size-fits-all number.

How Many IVF Cycles Are Needed for Success? Clinical Data Answers

There is no fixed number for how many IVF cycles are needed for success. According to data from domestic reproductive centers, the cumulative live birth rate varies significantly by age group:

  • Under 35 years old: The cumulative live birth rate after 3 egg retrieval cycles is approximately 70%–80%;
  • 35–40 years old: The cumulative live birth rate after 3 cycles is approximately 40%–60%;
  • Over 40 years old: The cumulative live birth rate after 3 cycles drops to 10%–20%.

These data indicate that age is the primary factor affecting the number of successful cycles. However, cumulative live birth rates are population-based statistics, and individual variation is large. Some succeed in one cycle, while others may need 4–5 cycles. The key is to identify the critical variables affecting success and address them specifically.

Why Does the Number of Successful Cycles Vary Individually?

The number of successful IVF cycles is influenced by multiple factors. From a reproductive medicine perspective, the core factors include the following three aspects:

Ovarian Reserve Function

Ovarian reserve directly determines the number of eggs that can be retrieved in one cycle. AMH, FSH, and antral follicle count are core indicators for assessing ovarian reserve. AMH above 1.2 ng/mL, FSH below 8 IU/L, and antral follicle count greater than 7 usually indicate good ovarian response and a higher probability of obtaining enough eggs in one cycle. Conversely, when AMH is below 0.5 ng/mL, the number of eggs retrieved per cycle may be low, potentially requiring multiple cycles to accumulate embryos.

Embryo Chromosomal Euploidy Rate

Normal embryo chromosomes are the foundation for implantation and development. Female age is positively correlated with the rate of embryonic chromosomal abnormalities. The euploidy rate in women under 35 is about 50%–60%, dropping to 20%–30% at age 40, and below 10% after 43. This means that with increasing age, more embryos are needed to obtain one chromosomally normal embryo, thereby increasing the number of cycles required for success.

Uterine Environment

Endometrial thickness, morphology, blood flow signals, and uterine cavity pathologies (such as polyps, adhesions, fibroids) all affect embryo implantation. Among patients with recurrent implantation failure, about 30%–40% have undetected uterine cavity issues. Hysteroscopy is the gold standard for diagnosis.

Reproductive Doctor's Perspective: How to Assess the Number of Cycles an Individual May Need

Clinically, doctors evaluate the potential number of cycles a patient may need through the following steps:

  • Step 1: Basic assessment. This includes AMH, FSH, LH, E2, antral follicle count, semen analysis, and chromosomal karyotype tests. These results provide an initial assessment of ovarian reserve and male factors.
  • Step 2: Trial cycle response assessment. The number of eggs retrieved, fertilization rate, and embryo development in the first stimulation cycle are important bases for determining subsequent cycle strategies. If the first cycle yields an ideal number of eggs and good embryo quality but fails to implant, the focus should shift to uterine factors and embryo chromosome screening. If the first cycle yields few eggs and poor embryo quality, the stimulation protocol may need adjustment, or egg donation may be considered.
  • Step 3: Embryo accumulation strategy. For patients with low ovarian reserve and few eggs retrieved, doctors may recommend 2–3 cycles of embryo accumulation. The embryos are then pooled for PGT screening before transfer. This strategy can improve the success rate of a single transfer and reduce the psychological burden of repeated transfers.

Differences in Success Rates Among Different Age Groups

Age Group Live Birth Rate per Cycle Cumulative Live Birth Rate (3 Cycles) Recommended Strategy
Under 35 40%–50% 70%–80% Conventional stimulation + fresh/frozen embryo transfer
35–37 30%–40% 50%–65% Conventional stimulation + PGT-A screening
38–40 20%–30% 40%–50% PGT-A screening + embryo accumulation
41–42 10%–15% 15%–25% Embryo accumulation + PGT-A + egg donation evaluation
Over 43 3%–8% 5%–12% Individualized protocol + egg donation evaluation
Data referenced from the annual report of the Chinese Medical Association's Reproductive Medicine Branch and clinical data from major domestic reproductive centers. Individual results may vary depending on specific causes and medical conditions.

Easily Overlooked Details

Fluctuation in Male Semen Quality

Male semen analysis results are not constant. Lifestyle habits, fever, medications, and environmental factors can all affect semen quality. It is recommended to maintain good lifestyle habits for 3 months before starting a cycle, avoid high-temperature environments, quit smoking, and limit alcohol. If the initial semen analysis is suboptimal, it should be repeated 2–3 times for a comprehensive assessment.

Vitamin D Levels

Recent studies have found that vitamin D deficiency is associated with lower IVF success rates. Vitamin D receptors are expressed in the endometrium and ovaries, playing a role in embryo implantation and immune regulation. It is recommended to check 25-hydroxyvitamin D levels before attempting pregnancy and to supplement if levels are below 30 ng/mL.

Chronic Endometritis

This is an easily overlooked abnormality of the endometrial microenvironment. It is difficult to detect with routine ultrasound and requires diagnosis through endometrial biopsy and CD138 immunohistochemical staining. Among patients with recurrent implantation failure, the detection rate of chronic endometritis is about 30%–50%. After antibiotic treatment, the success rate of subsequent transfers can be significantly improved in some patients.

Common Pitfalls

  • Blindly pursuing single-cycle success with excessive medication. Some patients, fearing failure in one cycle, ask doctors to use high doses of stimulation drugs. However, overstimulation not only increases the risk of OHSS (ovarian hyperstimulation syndrome) but may also affect egg quality. Ovarian stimulation protocols should be individualized; higher doses are not necessarily better.
  • Ignoring the necessity of embryo chromosome screening. For women over 38, the rate of embryonic chromosomal abnormalities increases significantly. Directly transferring unscreened embryos may lead to repeated implantation failure or early miscarriage. Many people mistakenly attribute this to "physical problems" or "bad luck," when it is actually due to embryonic chromosomal abnormalities.
  • Frequently changing hospitals and doctors. IVF is a process that requires continuity and accumulation. The laboratory conditions, embryo culture systems, and the doctor's understanding of a patient's ovarian response all need time to align. Frequently changing hospitals means starting over with reassessment and adjustment each time, which may actually prolong the path to success.

Timeline of an IVF Cycle

A complete IVF cycle typically takes 2–3 months and includes the following stages:

  • Pre-treatment testing phase (about 2–4 weeks). Female tests: AMH, FSH, LH, E2, thyroid function, infectious disease screening, chromosomal karyotype, uterine ultrasound, etc. Male tests: semen analysis, infectious disease screening, chromosomal karyotype, etc.
  • Ovarian stimulation phase (about 10–14 days). Daily injections of gonadotropins, with regular monitoring of follicle development and hormone levels.
  • Egg retrieval procedure (about 30 minutes). Usually performed on day 12–14 of stimulation. Patients rest for 2–4 hours after retrieval before being discharged.
  • Embryo culture phase (3–6 days). Cleavage-stage embryo transfer can be performed on day 3, and blastocyst transfer on day 5–6. If PGT screening is required, an additional 2–4 weeks of waiting is needed.
  • Embryo transfer procedure (about 10 minutes). Patients generally rest for 30 minutes after transfer before resuming normal activities.
  • Pregnancy test (10–14 days after transfer). A blood test for β-hCG to confirm pregnancy.

If embryo accumulation is needed, the stimulation and egg retrieval steps are repeated in the above process, with an interval of 1–2 menstrual cycles between each.

Frequently Asked Questions

Q1: Can I still do IVF with low AMH?
Low AMH does not mean IVF is impossible, but the number of eggs retrieved per cycle may be low. For patients with AMH below 0.5 ng/mL, an embryo accumulation strategy is recommended: undergo 2–3 stimulation cycles, pool the embryos for PGT screening, and then transfer to improve the success rate per transfer.
Q2: Do I need to prepare my body before IVF?
Yes. It is recommended to start lifestyle adjustments 3 months before starting a cycle: maintain a regular routine, quit smoking and limit alcohol, engage in moderate exercise, and supplement with folic acid and Coenzyme Q10. Men can also supplement with zinc, selenium, and L-carnitine. However, it is important to understand that preparation cannot reverse ovarian aging; it can only improve egg and sperm quality.
Q3: What preparations are needed for advanced maternal age IVF?
For advanced-age patients (over 38), it is recommended to complete the following: comprehensive ovarian reserve assessment, hysteroscopy, chromosomal karyotype analysis for both partners, and genetic counseling. At the same time, have realistic expectations, as the success rate per cycle is indeed lower for older patients, and multiple attempts may be necessary.
Q4: When should IVF tests be done?
Pre-treatment tests should ideally be completed 3–6 months before planning to start a cycle. Some test results have validity periods: infectious disease screening (6 months), chromosomal karyotype (lifelong validity), semen analysis (3–6 months). AMH testing is not affected by the menstrual cycle and can be done anytime. The six hormone levels and antral follicle count are best checked on days 2–4 of the menstrual cycle.
Q5: Which has a higher success rate, frozen embryo transfer or fresh embryo transfer?
For patients with high ovarian response or suboptimal endometrial conditions, frozen embryo transfer (FET) generally has a higher live birth rate than fresh embryo transfer. FET avoids the impact of hormonal fluctuations after stimulation on the endometrium and allows time for PGT screening. However, for patients with normal ovarian response and good endometrial morphology, the success rate of fresh embryo transfer is similar to that of frozen embryo transfer.
📋 Advice from a Reproductive Doctor to Patients

1. Establish reasonable expectations based on scientific data. Understand the success rate range corresponding to your age and ovarian reserve, and avoid being misled by false promises.

2. Choose a reputable reproductive center. The laboratory conditions and quality control system of a reputable center are fundamental guarantees for success.

3. Be mentally and financially prepared. IVF is not only a medical process but also a long-term psychological and financial investment. Planning ahead can reduce the likelihood of giving up midway.

4. Do not dismiss all possibilities after one failure. Each cycle is an opportunity to gather individual medical data, helping the doctor adjust the strategy for the next stage.

5. Focus on the quality of the process, not the number of cycles. Ensuring each cycle is standardized and thoroughly evaluated is more meaningful than blindly pursuing "success in one attempt."

Comments (0)

Leave a Comment